Baba Ramdev’s sermons on Patanjali’s cure-all drugs are flirting with the law

The yoga tycoon’s endorsement of Patanjali products as cures for chronic conditions raises ethical and legal questions.

4 March, 202312 min
0
Baba Ramdev’s sermons on Patanjali’s cure-all drugs are flirting with the law

Why read this story?

Editor's note: For the past three years, Baba Ramdev has been headlining a special programme on India TV. The show, called “Yog ke Rang, Swami Ramdev Ke Sang”, is broadcast between 8 and 9 am every day. It follows a template the yoga guru is best known for: leading viewers through various yoga poses. Often, he doubles up as an ayurveda expert, doling out remedies for a host of diseases. On 9 February, while Ramdev was in the middle of a leg raise, the anchor asked him a question about glaucoma. “They say this disease can only be controlled, not cured,” the anchor said. “Once your eye is injured, a glaucoma infection is said to be inevitable. How does one treat it?” “What you say is something that would have happened 30 years ago,” said Ramdev, settling into a lotus position. “But unfortunately, allopathy, which considers itself a superpower, is a victim of such misconceptions. Like you can’t get rid of spectacles.” Nearly a decade ago, he went on, the late BJP leader Bhairon Singh Shekhawat had come to inaugurate a Patanjali …

You may also like

Health
Story image

Indian pharma exporters protesting against new regulations is not a good look

The rules require exporters of certain drugs to get an NOC from importing countries—a small but much-needed step to restoring India’s credibility in the global pharma market.

Business
Story image

For Sun Pharma’s Dilip Shanghvi, specialty drugs remain the magic bullet

Specialty drugs are fast becoming a lucrative market globally. And India’s largest drugmaker has done well to make the most of this opportunity so far. But it’s too soon to rest easy.

Business
Story image

Can India finally rein in misleading claims in advertisements?

The Supreme Court has mandated all advertisers to submit self-declarations certifying that their ads had no bogus claims. Easier said than implemented.